Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 200,000 shares at $90.27 ($18.1M) on 2025-08-20, disclosed to the SEC on 2025-08-22.
Open-market sale of $18.1M ANIP by HEAD OF R&D, COO-NOVITIUM Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.27 | 47,012 | $4.2M | 23.5% |
| 2 | $90.27 | 47,012 | $4.2M | 23.5% |
| 3 | $90.44 | 52,988 | $4.8M | 26.5% |
| 4 | $90.44 | 52,988 | $4.8M | 26.5% |
| Total | $90.36 avg | 200,000 | $18.1M | 100% |
| Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |
| ANIP | SELL | 2024-06-24 | $1.2M | — | Filing → |